Cancer Research Technology
Log in Register
Menu

Anti-CEA [161 (NCRC16)]

Invented by Prof Lindy Durrant from University of Nottingham
Invented at University of Nottingham

Info

Catalogue Number 151306
Applications ELISA IP WB
Antigen/Gene or Protein Targets Carcinoembryonic Antigen (CEA)
Reactivity Human
Relevance Carcinoembryonic antigen is a diagnostic marker for many cancers including colorectal, hepatoma, neuroendocrine, lung, neuroblastoma, breast, pancreatic, trophoblastic and ovarian cancers.
Host Mouse
Immunogen Colon cancer cell lines
Positive Control LS174 T cells, colon carcinoma
Subclass IgG1
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions DMEM + 5% FCS
Research Area Cancer, Cell Type or Organelle Marker

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485.


Add a reference

References: 1 entry

Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485.


Add a reference